Demographic, clinical and laboratory variables of included patients across all admissions
| Variables | All patients, all admissions (N=247 650) |
| Age (years), mean (SD) | 60.7 (9.0) |
| Gender (male), n (%) | 242 088 (97.8) |
| Race, n (%) | |
| Caucasian | 182 638 (73.7) |
| African–American | 45 317 (18.3) |
| Asian–Hawaiian–Pacific Islander | 4018 (1.6) |
| American Indian–Alaskan Native | 3940 (1.6) |
| Unknown | 11 737 (4.7) |
| Aetiology, n (%) | |
| Alcoholic | 76 591 (30.9) |
| Viral (hepatitis B and C) | 35 189 (14.2) |
| Alcoholic and viral | 88 501 (35.7) |
| Non-alcoholic fatty liver disease | 30 921 (12.5) |
| Haemochromatosis | 1087 (0.4) |
| Autoimmune hepatitis | 393 (0.2) |
| Biliary cirrhosis | 1096 (0.4) |
| Other/cryptogenic | 40 309 (16.3) |
| Healthcareuse(past1 year) | |
| ER visits | 3.3 (6.4) |
| Inpatient hospitalisations | 2.3 (3.5) |
| Outpatient visits | 46.1 (50.6) |
| Non-face-to-face communication | 8.0 (10.2) |
| Congestive heart failure, n (%) | 57 290 (23.1) |
| Diabetes mellitus, n (%) | 103 260 (41.7) |
| History ofcirrhosiscomplications, n (%) | |
| Hepatic encephalopathy | 50 086 (20.2) |
| Varices | 48 016 (19.4) |
| Spontaneous bacterial peritonitis | 11 529 (4.7) |
| Ascites | 75 358 (30.4) |
| Hepatocellular carcinoma | 21 684 (8.8) |
| Hepatorenal syndrome | 4559 (1.8) |
| Vitals | |
| Systolic blood pressure | 125.8 (19.3) |
| Diastolic blood pressure | 73.1 (12.5) |
| Labs, median (IQR) | |
| Creatinine | 1.0 (0.8–1.3) |
| Blood urea nitrogen | 15.0 (10.0–21.0) |
| Sodium | 137.0 (134.0–139.0) |
| Total bilirubin | 1.1 (0.6–2.0) |
| Albumin | 3.2 (2.7–3.7) |
| International normalized ratio | 1.2 (1.1–1.4) |
| White blood cell | 6.0 (4.6–7.9) |
| Platelets | 132.0 (84.4–200.0) |
| Alanine aminotransferase | 34.0 (21.0–58.0) |
| Aspartate aminotransferase | 48.0 (29.0–85.0) |
| Riskscores | |
| MELD, mean (SD) | 12.7 (5.2) |
| MELD<12, n (%) | 135 287 (54.6) |
| MELD≥12 and <18, n (%) | 72 834 (29.4) |
| MELD≥18, n (%) | 39 529 (16.0) |
| MELD-Na, mean (SD) | 15.1 (5.6) |
| CLIF-C AD, mean (SD) | 50.3 (8.1) |
| Disposition, n (%) | |
| Home | 213 694 (86.3) |
| Hospice | 185 (0.1) |
| Hospital | 4938 (2.0) |
| In-hospital death | 10 630 (4.3) |
| Nursing home | 17 432 (7.0) |
| Other house | 179 (0.1) |
| Unknown | 1008 (0.4) |